Arkema (OTCMKTS:ARKAY) issued its quarterly earnings data on Thursday. The basic materials company reported $1.79 earnings per share for the quarter, Morningstar.com reports. Arkema had a return on equity of 12.48% and a net margin of 6.40%.
Shares of Arkema (OTCMKTS:ARKAY) traded up $4.22 on Thursday, hitting $131.96. The stock had a trading volume of 562 shares, compared to its average volume of 12,371. The firm has a market cap of $9,568.48, a price-to-earnings ratio of 15.88, a price-to-earnings-growth ratio of 0.93 and a beta of 1.19. The company has a current ratio of 2.11, a quick ratio of 1.57 and a debt-to-equity ratio of 0.52. Arkema has a one year low of $94.21 and a one year high of $133.05.
Several brokerages have recently commented on ARKAY. Credit Suisse Group lowered Arkema from a “neutral” rating to an “underperform” rating in a research report on Monday, November 13th. Zacks Investment Research upgraded Arkema from a “hold” rating to a “buy” rating and set a $139.00 target price for the company in a research report on Tuesday, January 9th.
ILLEGAL ACTIVITY WARNING: “Arkema (ARKAY) Announces Earnings Results” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/22/arkema-arkay-announces-earnings-results.html.
Arkema SA is a chemical producer, which provides specialty chemicals and advanced materials. The Company manufactures a range of products for industries, including construction, packaging, chemical, automotive, electronics, food and pharmaceutical industries. The Company operates through three business segments: High Performance Materials, Industrial Specialties and Coating Solutions.
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.